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who had 20-year history of Behçet’s disease presented with acutely blurred vision associated with orbital pain in both eyes. Visual
acuity was 0.4 in the right eye and light perception in the left eye; afferent pupillary defect was detected in the left eye. Bilateral
swelling of the optic disk was found. The cerebrospinal fluid sample tests were within normal limits. Brain magnetic resonance
imaging, magnetic resonance venography and fundus fluorescein angiography were normal. She was diagnosed with bilateral
optic neuritis and treated with intravenous methyl prednisolone for 10 days. As there was no response to the treatment, therapeu-
tic plasma exchange was started and the patient’s visual acuities improved moderately. We suggest that when high dose steroid is
failed to treat ON in BD, treatment with TPE may be considered.
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Behçet’s disease (BD) is a multisystem disease of unknown
cause in which an inflammatory perivasculitis can arise in
almost any tissue. It is manifested by a triad of relapsing uvei-
tis, aphthous stomatitis and genital ulcers.1 Central nervous
system (CNS) involvement is first described in 1941.2 Optic
neuritis (ON) has been reported rarely and bilateral simulta-
neous ON has been reported very rarely as a manifestation
of neuro-Behçet’s disease (NBD).3–10 Here we present a case
who had bilateral synchronous optic neuritis due to BD who
responds to therapeutic plasma exchange (TPE).Case report
Fifty-year old woman who had 20-year history of BD pre-
sented with acutely blurred vision associated with orbital
pain. She said that her vision became worse over two weeks.
Visual acuity was 0.4 in the right eye and light perception in
the left eye; afferent pupillary defect was detected in the left
eye. There was no finding of uveitis in ophthalmologic exam-
ination. Bilateral swelling of the optic disk and peripapillary
splinter hemorrhages in both eyes was found in her examina-







Fig. 1. Resolution of optic disk swelling in both eyes after TPE [(a): right, (b): left].
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tests, erythrocyte sedimentation rate, serum levels of
C-reactive protein and angiotensin converting enzyme were
all within normal limits. Serum neuromyelitis optica antibody
was negative. Magnetic resonance imaging (MRI) and mag-
netic resonance venography (MRV) of the brain were inconclu-
sive. Lumbar puncture was performed and the opening
pressure was 19 cm H20. The cerebrospinal fluid sample
(CSF) was acellular, the protein level was 25 mg/dl and the
glucose level was 66 mg/dl. Fundus fluorescein angiography
was normal. The patient was diagnosed with bilateral ON
secondary to BD. She was treated with intravenous methyl
prednisolone for 10 days at a dose of 1 gram daily. However,
the visual acuities became even worse during the treatment.
Just after steroid treatment TPE was started, totally 5 sessions
of TPE were carried out in every other days, and one plasma
volume was exchanged for each session. Following TPE treat-
ment bilateral optic disk swelling was improved on fundus
examination (Fig. 1). Three months after TPE the visual acuity
was 0.7 in the right eye and 0.1 in the left eye.
Discussion
Optic neuritis has been reported very rarely as a manifesta-
tion of NBD. In 1989, Kansu et al. reported three cases of ON
in BD.3 One of these cases was presented with bilateral syn-
chronous optic neuritis. Gallinaro et al. reported an acute pre-
sentation with unilateral neuropapillitis in a 34-year-old
woman with BD.4 Tarzi et al. reported a 32-year-old man with
a 4 year history of BD who had visual disturbance developed
over a period of hours with bilateral papillitis.5 Cranial MRI,
MRV and also the analysis of CSF were noted to be normal.
A well response to the treatment with intravenous methyl-
prednisolone at a dose of 1 g/daily was reported. Yalcindag
et al. reported a 47-year-old man of BD who had acute unilat-
eral ON.6 The authors described that the patient showed
improvement in two weeks after the treatment with intra-
venous prednisolone at a dose of 1 gram daily. Two cases with
the recurrent ON were reported by Voros et al. 7. The times of
ON attacks were noted similar with systemic relapses and one
attack was presented as bilateral ON. The authors prescribed
oral prednisolone for each attack and only one attack did not
response to the treatment and permanent visual loss
occurred. Nanke et al. reported a 27-year-old man of BD
who had recurrent unilateral ON and responded to oral pred-
nisolone treatment.8 Cetin et al. reported unilateral opticneuropathy in a 57-year-old man of BD.9 He was treated with
systemic steroid but there was no response to the treatment.
A 12-year-old boy with acute episcleritis and papillitis as pre-
sentations of pediatric BD was reported by Parentin et al. 10.
After treatment with oral prednisone 1 mg/kg, visual acuity
and fundus appearance returned to normal within one week.
The authors reported that in the following six months the dis-
ease relapsed four times in both eyes and oral cyclosporine
was given. Under oral cyclosporine treatment another two
episodes occurred so, intravenous infliximab treatment was
started. A well response was noted to the treatment. In a
review published in 2013, 20 cases of BD with primary inflam-
matory optic neuropathy were reported. Four of these cases
were bilateral and synchronous.11 Recently, Shokoohi and
Yakhoobi reported a 28-year-old Iranian man of Behçet’s
Disease presenting with bilateral papillitis who he showed
improvement with steroid treatment.12
In summary bilateral synchronous optic neuropathy has
been rarely reported in the literature.10,12 To our knowledge,
this is the sixth case with bilateral synchronous optic neuropa-
thy due to NBD. It may present solitary without parenchymal
NBD, such as our patient.5–12 The severity of visual loss and
the degree of response to the treatments can vary but
patients usually benefit from the steroid treatment.
It has been suggested that TPE is an effective treatment in
neurologic diseases that autoimmunity plays an important
role in the pathogenesis.13 TPE can be used in several neuro-
logical diseases such as acute disseminated encephal-
omyelitis, Guillain–Barre Syndrome, Myasthenia Gravis and
neuromyelitis optica according to the Guidelines on the
Use of Therapeutic Apheresis in Clinical Practice-Evidence-
Based Approach from the Writing Committee of the
American Society for Apheresis.14 NBD is not in any of its
recommendations. However, there have been some reports
suggesting TPE is effective when used in a group of autoim-
mune diseases including Behçet’s Disease.15 Since the visions
of the patient decreased during high dose steroid treatment,
the patient was put on TPE just after the treatment with ster-
oid. After the beginning of TPE, initially visual acuity
improved slightly, and then improvement continued, finally
the visual acuity improved moderately. The improvement
may be secondary to TPE or to the treatment with intra-
venous methyl prednisolone, or it may be spontaneous
improvement over time. However, it may be helpful to keep
in mind that when high dose steroid fails to treat ON in BD,
TPE may be tried as a second line treatment.
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